RESUMO
In order to establish a relationship between upper GI symptoms and CAPD therapy, 34 CAPD patients underwent UGI endoscopy and X-ray studies. Endoscopy is more specific than upper GI X-ray series in the diagnosis of gastrointestinal lesions.
Assuntos
Gastroenteropatias/etiologia , Diálise Peritoneal Ambulatorial Contínua/efeitos adversos , Adulto , Cimetidina/uso terapêutico , Endoscopia Gastrointestinal , Esofagite/diagnóstico , Esofagite/tratamento farmacológico , Esofagite/etiologia , Feminino , Gastrite/diagnóstico , Gastrite/tratamento farmacológico , Gastrite/etiologia , Gastroenteropatias/diagnóstico , Gastroenteropatias/tratamento farmacológico , Humanos , Masculino , Úlcera Péptica/diagnóstico , Úlcera Péptica/tratamento farmacológico , Úlcera Péptica/etiologiaRESUMO
Insulin resistance in uremia has been attributed to impaired hormone-receptor binding or to postbinding defects. Oral glucose tolerance tests, insulin binding, and in vitro glycolytic activity were studied in purified red blood cells from normal control subjects (C) and from uremic patients belonging to three groups: nondialyzed (U), on chronic hemodialysis (HD), and on continuous ambulatory peritoneal dialysis (CAPD). Glucose intolerance and hyperinsulinemia were demonstrated in all groups of patients. Maximal specific binding of 125I-insulin to erythrocytes, kinetically derived receptor numbers per cell, and affinity constants for insulin binding did not differ between control and patient groups. No correlation was found between the degree of glucose intolerance and insulin binding parameters. Basal lactate production by erythrocytes incubated in vitro was significantly higher in U and HD patients than in C, whereas CAPD patients did not differ from C in this respect. Addition of 1 mM dibutyryl-cAMP and 0.5 mM isobutyl-methyl-xanthine during incubation of erythrocytes caused an increase in the rate of lactate production that was similar in magnitude in the U, HD and C groups, whereas cells from CAPD subjects showed a significantly larger absolute response to these compounds after 1 h of incubation. There was no evidence of impairment of glycolytic capacity in red blood cells from uremic patients. In addition, no correlation was found between the degree of glucose intolerance and basal or stimulated lactate production by erythrocytes. Our results obtained in human erythrocytes suggest that the insulin resistance observed in uremia does not involve a defect in hormone binding or in the intracellular capacity to utilize glucose through glycolysis.
Assuntos
Eritrócitos/metabolismo , Glicólise , Resistência à Insulina , Falência Renal Crônica/sangue , Receptor de Insulina/metabolismo , Diálise Renal , Adulto , Teste de Tolerância a Glucose , Humanos , Técnicas In Vitro , Falência Renal Crônica/terapia , Lactatos/biossíntese , Ácido Láctico , Diálise Peritoneal Ambulatorial ContínuaAssuntos
Diabetes Mellitus/terapia , Falência Renal Crônica/terapia , Diálise Peritoneal Ambulatorial Contínua , Diálise Peritoneal , Complicações do Diabetes , Diabetes Mellitus/mortalidade , Humanos , Insulina/administração & dosagem , Falência Renal Crônica/complicações , Falência Renal Crônica/mortalidadeRESUMO
Twenty diabetics with end-stage renal disease who had never previously received dialysis treatment were treated with continuous ambulatory peritoneal dialysis for periods of two to 36 months (average, 14.5). Intraperitoneal administration of insulin achieved good control of blood sugar. Even though creatinine clearance decreased significantly (P = 0.001), control of blood urea nitrogen and serum creatinine was adequate. Hemoglobin and serum albumin levels increased significantly (P = 0.005 and 0.04, respectively). Similarly, there was a significant increase in serum triglycerides and alkaline phosphatase (P = 0.02 and 0.05). Blood pressure became normal without medications in all but one of the patients. Retinopathy, neuropathy, and osteodystrophy remained unchanged. Peritonitis developed once in every 20.6 patient-months--a rate similar to that observed in nondiabetics. The calculated survival rate was 93 per cent at one year; the calculated rate of continuation on ambulatory peritoneal dialysis was 87 per cent. We conclude that continuous ambulatory dialysis with intraperitoneal administration of insulin is a good alternative treatment for diabetics with end-stage renal disease.